11.12.2009
- William Mann, has been appointed as new CEO in the American subsidiary, Helsinn Therapeutics (U.S.). William Mann, was already COO of the recently acquired Helsinn Therapeutics...
11.12.2009
- Ashland completed the sale of its global marine services business, known for many years as Drew Marine, to J. F. Lehman & Co. for approximately $120 million before tax. Ashland...
11.12.2009
- Bristol-Myers Squibb said it will sell Asia rights to over-the-counter drugs and its Indonesian unit to Japan's Taisho Pharmaceutical for $310 million, its seventh deal aimed at...
11.12.2009
- Sanofi-Aventis has completed the acquisitions of a 50 % stake in animal health firm Merial from joint venture partner Merck & Co. for $4.0 billion in a deal that will be earnings...
11.12.2009
- Germany's Bayer has appointed the head of U.S. lab equipment maker Thermo Fisher Scientific as chief executive as part of a management overhaul likely to focus it more sharply on...
11.12.2009
- Dutch biotechnology firm Crucell said Johnson & Johnson had bought 14.6 million new Crucell shares for €302 million ($443.5 million) as part of a flu vaccine development deal...
11.12.2009
- Points Of View - Depending on who you ask the list of trends in the pharmaceutical industry grows from using bigger and more complicated synthesis components, and bioconjugation...
11.12.2009
- Chemcon Europe 2010, the leading international conference on chemical control legislation and trade aspects, will be held in Prague from March 1 - 5, 2010. Chemcon Europe is a...
- Merck presented the first group of new Pyrisma effect pigments. The Pyrisma brand stands for a new generation of effect pigments that the company has developed in close cooperation...
11.12.2009
- This years CPhI Worldwide, the leading exhibition on pharmaceutical ingredients and allied industries, takes place from October 13 - 15, in Madrid, Spain. Ahead of the event, where...
